天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 111-87-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 111-87-5
Chemical Structure| 111-87-5
Structure of 111-87-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 111-87-5 ]

Related Doc. of [ 111-87-5 ]

Alternatived Products of [ 111-87-5 ]
Product Citations

Product Citations

Cure, Hannah L ; Shell, Thomas A ; DOI:

Abstract: Substituting hydrogen atoms with fluorine alters physicochemical properties often resulting in improved drug action relative to the parent molecule. The high electronegativity of fluorine changes the electron density distribution of the molecule; however, the substitution does not significantly change the size of the molecule because hydrogen and fluorine have similar atomic radii. A trifluoroacetamido derivative (TFA-phenacetin) of phenacetin, an analgesic antipyretic drug, was synthesized to compare its lipophilicity to the parent molecule by determining octanol–water partition coefficients. TFA-phenacetin is over seven times more lipophilic than phenacetin, which suggests that TFA-phenacetin would have better bioavailability relative to phenacetin. The kinetics of cytochromes P-450 (CYP) catalyzed oxidation of phenacetin and TFA-phenacetin were compared using Sprague Dawley (SD) rat liver microsomes. Phenacetin and TFA-phenacetin have the same apparent binding affinity for the SD rat liver microsome CYP proteome and undergo CYP catalyzed oxidation at the same rate in the presence of SD rat liver microsomes.

Keywords: Phenacetin ; Fluorine derivative ; Lipophilicity

Purchased from AmBeed: ;

Product Details of [ 111-87-5 ]

CAS No. :111-87-5 MDL No. :MFCD00002988
Formula : C8H18O Boiling Point : -
Linear Structure Formula :H3C(CH2)7OH InChI Key :KBPLFHHGFOOTCA-UHFFFAOYSA-N
M.W : 130.23 Pubchem ID :957
Synonyms :
Octanol
Chemical Name :n-Octanol

Calculated chemistry of [ 111-87-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 6
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.73
TPSA : 20.23 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.96 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.51
Log Po/w (XLOGP3) : 3.0
Log Po/w (WLOGP) : 2.34
Log Po/w (MLOGP) : 2.22
Log Po/w (SILICOS-IT) : 2.14
Consensus Log Po/w : 2.44

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.14
Solubility : 0.94 mg/ml ; 0.00722 mol/l
Class : Soluble
Log S (Ali) : -3.09
Solubility : 0.106 mg/ml ; 0.000814 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.49
Solubility : 0.423 mg/ml ; 0.00325 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.44

Safety of [ 111-87-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P210-P264-P273-P280-P305+P351+P338-P337+P313-P370+P378-P403+P235-P501 UN#:N/A
Hazard Statements:H227-H319-H402-H412 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 111-87-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 111-87-5 ]
  • Downstream synthetic route of [ 111-87-5 ]

[ 111-87-5 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 111-87-5 ]
  • [ 62-90-8 ]
Reference: [1] Patent: US3959322, 1976, A,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;